SUN PHARMA ADV.RES.CO.LTD (SPARC)

NSE: ₹212.97
BSE: ₹212.90
Stock Performance
Corporate Announcements
Statutory Auditors Certificate In Terms Of Regulation 169(5) Of SEBI ICDRA Regulations, 2018

Statutory Auditors Certificate in terms of Regulation 169(5) of SEBI ICDRA Regualations, 2018

2026-05-25 20:55:39
Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Advertisement for Publication of Financials

2026-05-20 12:29:44
Update On PDP-716 NDA

Update on PDP-716 NDA

2026-05-19 18:47:59
Announcement under Regulation 30 (LODR)-Allotment

Allotment of 3,85,10,000 warrants pursuant to Preferential Issue

2026-05-19 12:42:23
Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Financial Year Ended March 31, 2026

the Audited Financial Results of the Company for the Quarter and Financial Year ended March 31, 2026

2026-05-11 19:05:39
Announcement under Regulation 30 (LODR)-Press Release / Media Release

SPARC Annouces Sale of Priority Review Voucher for US $195 million

2026-04-30 09:06:30
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018

2026-04-06 16:49:11
Announcement under Regulation 30 (LODR)-Change in Management

Intimation Regarding Resignation of Dr. Shravanti Bhowmik as Head of Operations Management of the Company w.e.f. April 01, 2026

2026-04-03 12:31:54

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 23.95 21.18 13.86 16.56 16.81 12.86 14.91 27.19 9.64 7.86 8.45 1,853.22
YOY Revenue Growth % -15.85% -32.85% -89.43% -65.28% -29.81% -39.28% 7.58% 64.19% -42.65% -38.88% -43.33% 6715.81%
Other Income 10.19 8.49 6.39 4.40 1.56 0.04 0.19 0.00 9.02 0.01 0.00 1.80
Total Income 34.14 29.67 20.25 20.96 18.37 12.90 15.10 27.19 18.66 7.87 8.45 1,855.02
Total Expenses + 129.49 116.09 119.90 127.65 115.21 120.59 94.81 88.17 70.69 83.84 76.66 94.32
Cost of Materials Consumed 5.17 6.47 9.03 7.46 4.53 8.31 4.58 5.70 5.13 6.10 7.21 5.16
Employee Benefit Expense 31.12 30.71 29.98 26.72 28.94 28.78 26.41 24.83 27.68 26.19 26.90 21.08
Other Expenses 89.84 75.47 77.47 89.90 78.46 79.62 58.30 50.58 29.16 41.46 31.21 54.04
Operating Profit -105.54 -94.91 -106.04 -111.09 -98.40 -107.73 -79.90 -60.98 -61.05 -75.98 -68.21 1,758.90
OPM % -440.7% -448.1% -765.1% -670.8% -585.4% -837.7% -535.9% -224.3% -633.3% -966.7% -807.2% 94.9%
Profit Before Tax + -95.35 -86.42 -99.65 -106.69 -96.84 -107.69 -79.71 -60.98 -52.03 -75.97 -80.57 1,760.70
Tax Expense 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Tax % - - - - - - - - - - - 0%
Profit After Tax -95.35 -86.42 -99.65 -106.69 -96.84 -107.69 -79.71 -60.98 -52.03 -75.97 -80.57 1,760.70
EPS (Basic) -2.94 -2.66 -3.07 -3.29 -2.98 -3.32 -2.46 -1.88 -1.60 -2.34 -2.48 54.26

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Revenue from Operations 1,879.17 71.77 75.55 238.78 137.25 252.96 76.82
YOY Revenue Growth % 2518.32% -5% -68.36% 73.97% -45.74% 229.29% -
Other Income 10.83 1.79 29.47 10.88 6.84 5.41 9.76
Total Income 1,890.00 73.56 105.02 249.66 144.09 258.37 86.58
Total Expenses + 325.51 418.78 493.13 472.24 347.49 409.51 386.83
Cost of Materials Consumed 23.60 23.12 28.13 22.11 18.27 18.18 23.92
Employee Benefit Expense 101.85 108.96 118.53 106.99 96.78 91.58 93.09
Other Expenses 155.87 266.96 332.68 323.74 208.95 278.18 269.82
Operating Profit 1,553.66 -347.01 -417.58 -233.46 -210.24 -156.55 -310.01
OPM % 82.7% -483.5% -552.7% -97.8% -153.2% -61.9% -403.6%
Profit Before Exceptional 1,564.49 -345.22 -388.11 -222.58 -203.40 -151.14 -312.40
Exceptional Items -12.36 0.00 0.00 0.00 0.00 0.00 0.00
Profit Before Tax + 1,552.13 -345.22 -388.11 -222.58 -203.40 -151.14 -312.40
Tax Expense 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Tax % 0% - - - - - -
Profit After Tax 1,552.13 -345.22 -388.11 -222.58 -203.40 -151.14 -312.40
EPS (Basic) 47.83 -10.64 -11.96 -7.82 -7.73 -5.77 -11.92

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
ASSETS
Non-Current Assets + 306.60 304.02 239.93 375.17 208.94 166.58 0.00
Property, Plant & Equipment 85.18 95.27 102.46 105.41 91.40 89.87 0.00
Capital Work in Progress 0.50 0.56 1.26 1.87 3.72 5.23 0.00
Non-Current Investments 0.43 0.42 0.00 0.00 0.00 0.00 0.00
Goodwill 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 0.13 0.06 0.19 0.34 0.47 0.69 0.00
Current Assets + 1,861.38 25.27 246.40 454.95 71.14 59.81 0.00
Inventories 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Trade Receivables 8.27 16.06 15.53 32.71 27.74 17.58 0.00
Cash and Cash Equivalents 0.32 1.19 5.06 0.58 1.22 9.30 0.00
Current Investments 0.00 0.00 1.80 290.90 11.66 6.43 0.00
LIABILITIES & EQUITY
Total Equity 1,333.58 -220.62 124.85 512.77 31.23 -168.25 0.00
Equity Share Capital 32.45 32.45 32.45 32.45 27.19 26.21 0.00
Other Equity 1,301.13 -253.07 92.40 480.32 4.04 -194.46 0.00
Non-Current Liabilities 77.58 176.18 117.59 138.41 77.43 164.60 0.00
Current Liabilities 756.82 373.73 243.89 178.94 171.42 233.35 0.00
Total Liabilities 834.40 549.91 361.48 317.35 248.85 397.95 0.00

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Cash from Operating Activities -238.89 -362.41 -429.43 -69.12 -208.22 -151.89 0.00
Cash from Investing Activities -23.51 157.66 391.11 -548.28 -29.17 1.55 0.00
Cash from Financing Activities 261.53 200.88 42.80 616.76 229.32 159.29 0.00
Net Increase/Decrease in Cash -0.87 -3.87 4.48 -0.64 -8.07 8.95 0.00